117186-02-4 Usage
Uses
Used in Organic Synthesis:
3-METHYL-5-(TRIFLUOROMETHYL)BENZOIC ACID is used as a versatile intermediate in organic synthesis for the production of fluorinated organic compounds. Its trifluoromethyl group contributes to the reactivity and stability of the synthesized compounds, making it valuable in the creation of various chemical products.
Used in Pharmaceutical Industry:
In the pharmaceutical sector, 3-METHYL-5-(TRIFLUOROMETHYL)BENZOIC ACID serves as a building block for the synthesis of pharmaceutical drugs. Its unique structure allows for the development of new drug candidates with potential therapeutic benefits, including anti-inflammatory and anti-cancer properties.
Used in Agrochemicals:
3-METHYL-5-(TRIFLUOROMETHYL)BENZOIC ACID is also utilized in the agrochemical industry, where it acts as a key component in the synthesis of various agrochemicals. Its properties contribute to the effectiveness of these products in agricultural applications.
Used in Medicinal Research:
3-METHYL-5-(TRIFLUOROMETHYL)BENZOIC ACID is employed in medicinal research for its potential anti-inflammatory and anti-cancer properties. Its unique structure and reactivity make it an important chemical for the development of new therapeutic agents and the study of their mechanisms of action.
Check Digit Verification of cas no
The CAS Registry Mumber 117186-02-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,1,8 and 6 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 117186-02:
(8*1)+(7*1)+(6*7)+(5*1)+(4*8)+(3*6)+(2*0)+(1*2)=114
114 % 10 = 4
So 117186-02-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H7F3O2/c1-5-2-6(8(13)14)4-7(3-5)9(10,11)12/h2-4H,1H3,(H,13,14)
117186-02-4Relevant articles and documents
INHIBITORS OF STEAROYL-COA DESATURASE
-
, (2009/06/27)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.
